DK0783310T3 - Nye hormonpræparater og deres anvendelse til afhjælpning af østrogenmangel - Google Patents

Nye hormonpræparater og deres anvendelse til afhjælpning af østrogenmangel

Info

Publication number
DK0783310T3
DK0783310T3 DK96923018T DK96923018T DK0783310T3 DK 0783310 T3 DK0783310 T3 DK 0783310T3 DK 96923018 T DK96923018 T DK 96923018T DK 96923018 T DK96923018 T DK 96923018T DK 0783310 T3 DK0783310 T3 DK 0783310T3
Authority
DK
Denmark
Prior art keywords
remedying
estrogen deficiency
hormone preparations
new hormone
new
Prior art date
Application number
DK96923018T
Other languages
Danish (da)
English (en)
Inventor
Michel Lanquetin
Jacques Paris
Jean-Louis Thomas
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9481610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0783310(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theramex filed Critical Theramex
Application granted granted Critical
Publication of DK0783310T3 publication Critical patent/DK0783310T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK96923018T 1995-08-01 1996-07-29 Nye hormonpræparater og deres anvendelse til afhjælpning af østrogenmangel DK0783310T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9509364A FR2737411B1 (fr) 1995-08-01 1995-08-01 Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
PCT/IB1996/000754 WO1997004784A1 (fr) 1995-08-01 1996-07-29 Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques

Publications (1)

Publication Number Publication Date
DK0783310T3 true DK0783310T3 (da) 2003-02-10

Family

ID=9481610

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96923018T DK0783310T3 (da) 1995-08-01 1996-07-29 Nye hormonpræparater og deres anvendelse til afhjælpning af østrogenmangel

Country Status (31)

Country Link
US (1) US5891867A (xx)
EP (1) EP0783310B1 (xx)
JP (1) JPH10507207A (xx)
KR (1) KR100450649B1 (xx)
CN (1) CN1138547C (xx)
AP (1) AP829A (xx)
AR (1) AR004502A1 (xx)
AT (1) ATE225659T1 (xx)
AU (1) AU722355B2 (xx)
BR (1) BR9606549A (xx)
CA (1) CA2201368C (xx)
CZ (1) CZ289706B6 (xx)
DE (1) DE69624214T2 (xx)
DK (1) DK0783310T3 (xx)
DZ (1) DZ2078A1 (xx)
ES (1) ES2184880T3 (xx)
FR (1) FR2737411B1 (xx)
HK (1) HK1005227A1 (xx)
HU (1) HU229843B1 (xx)
IL (1) IL120558A (xx)
MA (1) MA23946A1 (xx)
MX (1) MX9702381A (xx)
MY (1) MY117307A (xx)
NO (1) NO312996B1 (xx)
OA (1) OA10411A (xx)
PT (1) PT783310E (xx)
RU (1) RU2188641C2 (xx)
TN (1) TNSN96101A1 (xx)
TW (1) TW473390B (xx)
WO (1) WO1997004784A1 (xx)
ZA (1) ZA966545B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030355A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
WO2001030356A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
US20020151732A1 (en) * 2001-01-05 2002-10-17 Claes Ohlsson Estrogen receptors
CA2446849A1 (en) * 2001-05-16 2002-11-21 Endeavor Pharmaceuticals Treatment of conditions relating to hormone deficiencies by administration of progestins
EP1453521B1 (en) 2001-12-05 2013-09-04 Teva Women's Health, Inc. Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
US7008979B2 (en) * 2002-04-30 2006-03-07 Hydromer, Inc. Coating composition for multiple hydrophilic applications
CN101001631B (zh) * 2003-07-16 2014-08-06 特卫华妇女健康有限公司 利用连续给予雌激素的避孕方案的激素治疗方法
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US8022053B2 (en) * 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
US20080242650A1 (en) * 2007-03-26 2008-10-02 Jean-Louis Thomas Oral contraceptive regimen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
FR2695826B1 (fr) * 1992-09-21 1995-01-06 Theramex Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.

Also Published As

Publication number Publication date
FR2737411B1 (fr) 1997-10-17
AP9700979A0 (en) 1997-07-31
AU6367496A (en) 1997-02-26
DE69624214D1 (de) 2002-11-14
MX9702381A (es) 1998-02-28
FR2737411A1 (fr) 1997-02-07
EP0783310B1 (fr) 2002-10-09
WO1997004784A1 (fr) 1997-02-13
HUP9900612A2 (hu) 1999-07-28
NO312996B1 (no) 2002-07-29
MA23946A1 (fr) 1997-04-01
HK1005227A1 (en) 1998-12-31
CA2201368C (fr) 2010-12-07
CN1138547C (zh) 2004-02-18
OA10411A (fr) 2001-12-06
KR970706004A (ko) 1997-11-03
CA2201368A1 (fr) 1997-02-13
BR9606549A (pt) 1998-06-23
AP829A (en) 2000-05-03
NO971449L (no) 1997-05-30
CZ289706B6 (cs) 2002-03-13
HUP9900612A3 (en) 1999-11-29
DE69624214T2 (de) 2003-07-10
CZ96797A3 (cs) 1998-08-12
CN1167438A (zh) 1997-12-10
RU2188641C2 (ru) 2002-09-10
PT783310E (pt) 2003-02-28
AR004502A1 (es) 1998-12-16
ZA966545B (en) 1997-05-08
JPH10507207A (ja) 1998-07-14
AU722355B2 (en) 2000-07-27
NO971449D0 (no) 1997-03-26
MY117307A (en) 2004-06-30
DZ2078A1 (fr) 2002-10-22
US5891867A (en) 1999-04-06
EP0783310A1 (fr) 1997-07-16
ES2184880T3 (es) 2003-04-16
TNSN96101A1 (fr) 2005-03-15
TW473390B (en) 2002-01-21
KR100450649B1 (ko) 2004-11-16
ATE225659T1 (de) 2002-10-15
HU229843B1 (en) 2014-09-29
IL120558A0 (en) 1997-07-13
IL120558A (en) 2002-09-12

Similar Documents

Publication Publication Date Title
NO942193D0 (no) Metallocener og fremgangsmåte til deres fremstilling og bruk
DK0486290T3 (da) Fremgangsmåde og præparat til forøgelse af akkumulering af squalen og specifikke steroler i gær
DK0767660T3 (da) Fremgangsmåder og formuleringer til modulering af seksualreaktionen hos mennesket
DK0822831T4 (da) Vacciner indeholdende en saponin og en sterol
IS4479A (is) Aðferð og lyfjablöndur til að koma af stað frumueitursvörun T-eitilfrumna
DK0909327T3 (da) Erythromyciner og fremgangsmåder til deres fremstilling
DE69603172D1 (de) Inphase- und quadraturabtastschaltung
DK80593D0 (da) Fremgangsmaade og anlaeg til udvejning af genstandsportioner
NO20071415L (no) OB-fusjonsproteinpreparater og fremgangsmater
NO992297D0 (no) FremgangsmÕte og nye forbindelser
NO972236D0 (no) Dihydropyrimidiner og anvendelse derav
NO985339D0 (no) Humane B-celleantigener og beslektede reagenser
NO943511L (no) Farmasöytiske preparater og anvendelse derav
NO305317B1 (no) Sulfonamid-endotelin-antagonister anvendelser derav og farmas°ytisk preparat
NO964958D0 (no) Aluminium-scandiumlegeringer og deres anvendelse
DK0898596T3 (da) Farvestoffer af kvadrattypen og deres anvendelse ved en fremgangsmåde til sekvensbestemmelse
DE69732689D1 (de) Durchfluss- und überlastregeleung in paketvermittelten netzen
DK0783310T3 (da) Nye hormonpræparater og deres anvendelse til afhjælpning af østrogenmangel
NO921012L (no) Farmasoeytiske preparater og deres anvendelse
DE69738634D1 (de) Bildselektions- und anzeigegerät
NO975711L (no) Nye Dolastatinderivater, deres fremstilling og anvendelse
NO973107D0 (no) Programmerte celledödgener og proteiner
DK1005501T3 (da) Nye blokcopolymerer og fremstilling af disse
BR9302447A (pt) Suporte para publicidade aplicavel em sombrinhas guarda-sois,guarda-chuvas e estruturas similares
NO973230D0 (no) Nye peptider, deres fremstilling og anvendelse